专利信息

查询条件展开筛选条件

[IPC] 包含 'B'

[专利权人] 包含 'TEVA PHARMA [IL]'

首页 1 2 3 4 5 下页尾页共 45 条记录, 当前第1/5页。

	公开号	公开日	申请号	申请日

首页 1 2 3 4 5 下页尾页共 45 条记录, 当前第1/5页。

当前查询条件: [IPC] 包含 'B' AND [专利权人] 包含 'TEVA PHARMA [IL]'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. IL156055A	2010/12/30	IL20030156055	2003/5/21
专利标题：CRYSTAL FORM VIII OF ATORVASTATIN HEMI- CALCIUM, PROCESSES FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION COMPRISING ATORVASTATIN HEMI-CALCIUM FORM VIII 专利权人：TEVA PHARMA [IL];

2. EP2194041A1	2010/6/9	EP20100151206	2001/11/29
专利标题：Novel crystal form IX of atorvastatin hemi-calcium and processes for its preparation 专利权人：TEVA PHARMA [IL]; The present invention provides a novel form of atorvastatin designated Form IX and novel processes for its preparation.

3. EP2192113A1	2010/6/2	EP20100152443	2001/11/29
专利标题：Novel crystal form XI of atorvastatin hemi-calcium and processes for its preparation 专利权人：TEVA PHARMA [IL]; The present invention provides a novel form of atorvastatin designated Form XI and novel processes for its preparation.

4. EP2192112A1	2010/6/2	EP20100151205	2001/11/29
专利标题：Process for preparing atorvastatin hemi-calcium Form I 专利权人：TEVA PHARMA [IL]; The present invention provides novel processes for preparing atorvastatin Form I.

5. EP1992629A1	2008/11/19	EP20080015768	2002/10/3
专利标题：Preparation of levofloxacin and forms thereof 专利权人：TEVA PHARMA [IL]; Levofloxacin was prepared by reacting (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid with N-methyl piperazine in a polar solvent or in a neat mixture to form levofloxacin. Further processing of the levofloxacin produced novel levofloxacin forms, including a hemihydrate and Forms A, B, C, F, G and H.

6. EP1783113A2	2007/5/9	EP20060024449	2001/11/29
专利标题：Crystal form VII of atorvastatin hemi-calcium 专利权人：TEVA PHARMA [IL]; The present invention provides novel forms of atorvastatin designated Forms VI, VII, VIII, IX, X, XI and XII and novel processes for their preparation as well as processes for preparing atorvastatin Forms I, II,IV, V and amorphous atorvastatin.

7. EP1772457A2	2007/4/11	EP20060020684	2002/10/3
专利标题：Preparation of levofloxacin and forms thereof 专利权人：TEVA PHARMA [IL]; Levofloxacin was prepared by reacting (S)-(-)-9,10-difluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid with N-methyl piperazine in a polar solvent or in a neat mixture to form levofloxacin. Further processing of the levofloxacin produced novel levofloxacin forms, including a hemihydrate and Forms A, B, C, F, G and H.

8. PT1451194E	2007/1/31	PT20020776152T	2002/10/3
专利标题：PREPARATION OF LEVOFLOXACIN HEMIHYDRATE 专利权人：TEVA PHARMA [IL];

9. US2006258676A1	2006/11/16	US20060488370	2006/7/17
专利标题：Novel crystalline forms of gatifloxacin and processes for preparation 专利权人：TEVA PHARMA [IL]; Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.

10. US2006258675A1	2006/11/16	US20060488368	2006/7/17
专利标题：Novel crystalline forms of gatofloxacin and processes for preparation 专利权人：TEVA PHARMA [IL]; Provided are novel crystalline forms of gatifloxacin, some of which are DMSO solvates, and methods for making them.

下载范围

下载内容